市場調査レポート

商品コード

1673585

マルチプレックスアッセイの市場規模、シェア、成長分析：製品タイプ別、タイプ別、技術別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Multiplex Assay Market Size, Share, and Growth Analysis, By Product Type (Consumables, Instruments), By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays), By Technology, By Application, By End-User, By Region - Industry Forecast 2025-2032

出版日: 2025年03月03日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

マルチプレックスアッセイ市場規模は2023年に37億米ドルと評価され、2024年の40億5,000万米ドルから2032年には83億7,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.5%で成長する見通しです。

世界のマルチプレックスアッセイ市場は、慢性疾患や感染症の有病率の増加や、従来の手法に対するマルチプレックスアッセイの優位性によって大きな成長を遂げています。コンパニオン診断薬の利用が増加していることは、dMMR固形がんを同定するためのRocheのようなFDA承認によって証明されており、この分野の将来が有望であることを示しています。非小細胞肺がんのようながんの生存率を3倍にする可能性のある早期診断が、市場の拡大可能性をさらに強調しています。さらに、バイオマーカーの検証や自動化システムの需要が、ハイスループットアッセイの必要性を高めています。がん、自己免疫疾患、神経変性疾患など幅広いアプリケーションに対応するマルチプレックスアッセイは、早期発見と認知度の向上に極めて重要であり、最終的に市場成長の原動力となります。

市場概要
タンパク質マルチプレックスアッセイ
- 平面タンパク質アッセイ
- ビーズベースのタンパク質アッセイ
- その他
核酸マルチプレックスアッセイ
- 平面核酸アッセイ
- ビーズベースの核酸アッセイ
- その他
細胞ベースのマルチプレックスアッセイ

マルチプレックスアッセイ市場規模：技術別& CAGR（2025-2032）

市場概要
フローサイトメトリー
蛍光検出
発光
マルチプレックスリアルタイムPCR
その他

マルチプレックスアッセイ市場規模：用途別& CAGR（2025-2032）

市場概要
研究開発
- 医薬品の発見と開発
- バイオマーカーの発見と検証
臨床診断
- 感染症
- がん
- 心血管疾患
- 自己免疫疾患
- 神経系疾患
- 代謝および内分泌疾患
- その他の病気

マルチプレックスアッセイ市場規模：エンドユーザー別& CAGR（2025-2032）

市場概要
製薬・バイオテクノロジー企業
病院・調査機関
リファレンスラボ
その他

マルチプレックスアッセイ市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Lonza Group（Switzerland）
DiaSorin（Italy）
WuXi Biologics（China）
Seegene（South Korea）
Ayoxxa Biosystems（Germany）
Thermo Fisher Scientific（United States）
Bio-Rad Laboratories（United States）
Luminex Corporation（United States）
QIAGEN（Germany）
Illumina（United States）
Agilent Technologies（United States）
PerkinElmer（United States）
Merck KGaA（Germany）
Becton, Dickinson and Company（United States）
Roche Diagnostics（Switzerland）
Siemens Healthineers（Germany）
Danaher Corporation（United States）
Abbott Laboratories（United States）
Meso Scale Diagnostics（United States）
Quanterix Corporation（United States）

結論と提言

Product Code: SQMIG35H2180

Multiplex Assay Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 4.05 billion in 2024 to USD 8.37 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The global multiplex assay market is experiencing significant growth driven by the increasing prevalence of chronic and infectious diseases and the advantages of multiplex assays over traditional methods. The rising utilization in companion diagnostics is particularly noteworthy, as evidenced by FDA approvals like Roche's for identifying dMMR solid tumors, indicating a promising future for this sector. Early disease diagnosis, which can triple survival rates for cancers such as non-small cell lung cancer, further emphasizes the market's expansion potential. Additionally, the validation of biomarkers and demand for automated systems bolster the need for high-throughput assays. With applications spanning cancer, autoimmune diseases, and neurodegenerative disorders, multiplex assays are pivotal in enhancing early detection and raising awareness, ultimately fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Multiplex Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Multiplex Assay Market Segments Analysis

Global Multiplex Assay Market is segmented by Product Type, Type, Technology, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software. Based on Type, the market is segmented into Protein Multiplex Assays, Nucleic Acid Multiplex Assays and Cell-based Multiplex Assays. Based on Technology, the market is segmented into Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-time PCR and Others. Based on Application, the market is segmented into Research & Development and Clinical Diagnostics. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Multiplex Assay Market

The increasing emphasis on personalized medicine is significantly fueling the growth of the multiplex assay market. These assays facilitate the simultaneous analysis of several biomarkers, which enhances patient stratification and leads to more tailored treatment options. By enabling healthcare providers to assess multiple health indicators at once, multiplex assays contribute to more accurate diagnoses and effective therapeutic strategies. This capability not only optimizes patient care but also supports the shift towards individualized therapies that cater to specific patient needs, thus reinforcing the demand for these advanced diagnostic tools in clinical settings.

Restraints in the Multiplex Assay Market

The multiplex assay market faces significant restraints primarily due to regulatory challenges that can hinder their widespread adoption. The complex nature of these assays necessitates obtaining regulatory approval, a process that is often time-consuming and financially burdensome. Such stringent requirements can deter manufacturers from developing and introducing new multiplex assays into the market, ultimately slowing innovation and limiting the availability of these advanced diagnostic tools. Consequently, the lengthy regulatory procedures may restrict market growth and access to potentially valuable multiplex assays that could significantly enhance diagnostic accuracy and efficiency across various medical applications.

Market Trends of the Multiplex Assay Market

The multiplex assay market is witnessing a significant trend towards the adoption of multiplex immunoassays, driven by their efficiency in measuring multiple protein targets within a single sample. This capability not only streamlines workflows but also enhances the accuracy and throughput of diagnostic testing, drug discovery, and biomarker identification processes. As healthcare continues to shift towards personalized medicine and more precise diagnostics, the demand for these assays is expected to grow steadily. Furthermore, advancements in technology that facilitate higher sensitivity and multiplexing capabilities are propelling market growth, positioning multiplex immunoassays as essential tools in clinical research and therapeutics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Multiplex Assay Market Size by Product Type & CAGR (2025-2032)

Market Overview
Consumables
Instruments
Software

Global Multiplex Assay Market Size by Type & CAGR (2025-2032)

Market Overview
Protein Multiplex Assays
- Planar Protein Assays
- Bead-based Protein Assays
- Others
Nucleic Acid Multiplex Assays
- Planar Nucleic Acid Assays
- Bead-based Nucleic Acid Assays
- Others
Cell-based Multiplex Assays

Global Multiplex Assay Market Size by Technology & CAGR (2025-2032)

Market Overview
Flow Cytometry
Fluorescence Detection
Luminescence
Multiplex Real-time PCR
Others

Global Multiplex Assay Market Size by Application & CAGR (2025-2032)

Market Overview
Research & Development
- Drug Discovery & Development
- Biomarker Discovery & Validation
Clinical Diagnostics
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Autoimmune Diseases
- Nervous System Disorders
- Metabolism & Endocrinology Disorders
- Other Diseases

Global Multiplex Assay Market Size by End-User & CAGR (2025-2032)

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Others

Global Multiplex Assay Market Size & CAGR (2025-2032)

North America (Product Type, Type, Technology, Application, End-User)
- US
- Canada
Europe (Product Type, Type, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi Biologics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ayoxxa Biosystems (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meso Scale Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quanterix Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments